TY - JOUR KW - Adolescent KW - Adult KW - Animals KW - Antigens, Bacterial KW - Child KW - Female KW - Foot KW - Fusidic Acid KW - Glycolipids KW - Humans KW - Leprosy, lepromatous KW - Male KW - Mice KW - Microbial Sensitivity Tests KW - Mycobacterium leprae KW - polymerase chain reaction KW - Skin KW - Spirometry KW - Time Factors AU - Franzblau S G AU - Chan G P AU - Garcia-Ignacio B G AU - Chavez V E AU - Livelo J B AU - Jimenez C L AU - Parrilla M L AU - Calvo R F AU - Williams D L AU - Gillis T P AB -

Fusidic acid was assessed for antileprosy activity in nine lepromatous leprosy patients. Patients received fusidic acid at either 500 mg/day for 12 weeks or 750 mg/day for 4 weeks followed by 500 mg/day for 8 weeks. All patients showed time-dependent clinical improvement and decreases in bacillary morphological index, radiorespirometric activity and PCR signal, and in serum phenolic glycolipid I. Fusidic acid appears to be a weakly bactericidal antileprosy agent which may have a role in the multidrug treatment of leprosy pending an evaluation of lepra-reaction-suppressive activity.

BT - Antimicrobial agents and chemotherapy C1 - http://www.ncbi.nlm.nih.gov/pubmed/7979302?dopt=Abstract DA - 1994 Jul DO - 10.1128/aac.38.7.1651 IS - 7 J2 - Antimicrob. Agents Chemother. LA - eng N2 -

Fusidic acid was assessed for antileprosy activity in nine lepromatous leprosy patients. Patients received fusidic acid at either 500 mg/day for 12 weeks or 750 mg/day for 4 weeks followed by 500 mg/day for 8 weeks. All patients showed time-dependent clinical improvement and decreases in bacillary morphological index, radiorespirometric activity and PCR signal, and in serum phenolic glycolipid I. Fusidic acid appears to be a weakly bactericidal antileprosy agent which may have a role in the multidrug treatment of leprosy pending an evaluation of lepra-reaction-suppressive activity.

PY - 1994 SP - 1651 EP - 4 T2 - Antimicrobial agents and chemotherapy TI - Clinical trial of fusidic acid for lepromatous leprosy. VL - 38 SN - 0066-4804 ER -